Monoclonal antibody to the prostate specific antigen: Monoklonaler Antikörper gegen das Prostata-spezifische Antigen

Andrologia ◽  
2009 ◽  
Vol 22 (S1) ◽  
pp. 44-55
Author(s):  
F. Donn ◽  
T. Bruns ◽  
L. Meyerrinck ◽  
C. Augustin ◽  
M. Schulz ◽  
...  
2000 ◽  
Vol 234 (1-2) ◽  
pp. 99-106 ◽  
Author(s):  
Kyoichi Matsumoto ◽  
Noboru Konishi ◽  
Tomohiro Samori ◽  
Emi Kimura ◽  
Michiko Doi ◽  
...  

1998 ◽  
Vol 44 (6) ◽  
pp. 1216-1223 ◽  
Author(s):  
W Jeffrey Allard ◽  
Zeqi Zhou ◽  
Kwok K Yeung

Abstract Serum prostate-specific antigen (PSA) is an effective diagnostic tool for detection of prostate cancer (CaP) at an early and potentially curable stage, but specificity is low. Studies have shown that the proportion of serum PSA complexed with α-1-antichymotrypsin (ACT) is higher in men with CaP than in men with benign prostate disease. We developed a novel immunoassay for complexed PSA based on the unique binding properties of a monoclonal antibody that fails to bind free PSA in the presence of antibodies specific for free PSA. The assay measured mixtures of free and complexed PSA accurately, and the measured values of free + complexed PSA in artificial mixtures and in patient sera were equivalent to the measured value of total PSA. Both the serum concentration and the proportion of complexed PSA was substantially higher in patients with CaP compared with patients with benign prostate disease. The cPSA assay may have utility in improving specificity in screening for prostate cancer.


The Prostate ◽  
1996 ◽  
Vol 28 (1) ◽  
pp. 10-16 ◽  
Author(s):  
Tang J. Wang ◽  
Tim M. Hill ◽  
Roger L. Sokoloff ◽  
Francis Frankenne ◽  
Harry G. Rittenhouse ◽  
...  

2012 ◽  
Vol 9 (75) ◽  
pp. 2457-2467 ◽  
Author(s):  
Xiubo Zhao ◽  
Fang Pan ◽  
Luis Garcia-Gancedo ◽  
Andrew J. Flewitt ◽  
Gregory M. Ashley ◽  
...  

The specific recognition between monoclonal antibody (anti-human prostate-specific antigen, anti-hPSA) and its antigen (human prostate-specific antigen, hPSA) has promising applications in prostate cancer diagnostics and other biosensor applications. However, because of steric constraints associated with interfacial packing and molecular orientations, the binding efficiency is often very low. In this study, spectroscopic ellipsometry and neutron reflection have been used to investigate how solution pH, salt concentration and surface chemistry affect antibody adsorption and subsequent antigen binding. The adsorbed amount of antibody was found to vary with pH and the maximum adsorption occurred between pH 5 and 6, close to the isoelectric point of the antibody. By contrast, the highest antigen binding efficiency occurred close to the neutral pH. Increasing the ionic strength reduced antibody adsorbed amount at the silica–water interface but had little effect on antigen binding. Further studies of antibody adsorption on hydrophobic C8 (octyltrimethoxysilane) surface and chemical attachment of antibody on (3-mercaptopropyl)trimethoxysilane/4-maleimidobutyric acid N -hydroxysuccinimide ester-modified surface have also been undertaken. It was found that on all surfaces studied, the antibody predominantly adopted the ‘flat on’ orientation, and antigen-binding capabilities were comparable. The results indicate that antibody immobilization via appropriate physical adsorption can replace elaborate interfacial molecular engineering involving complex covalent attachments.


Langmuir ◽  
2011 ◽  
Vol 27 (12) ◽  
pp. 7654-7662 ◽  
Author(s):  
Xiubo Zhao ◽  
Fang Pan ◽  
Ben Cowsill ◽  
Jian R. Lu ◽  
Luis Garcia-Gancedo ◽  
...  

The Prostate ◽  
1989 ◽  
Vol 14 (3) ◽  
pp. 237-249 ◽  
Author(s):  
F. Donn ◽  
T. Bruns ◽  
L. von Meyerinck ◽  
M. Schulz ◽  
W.-M. Becker ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document